| ID |
Description |
GeneRatio |
BgRatio |
pvalue |
p.adjust |
qvalue |
geneID |
Count |
| hsa04060 |
Cytokine-cytokine receptor interaction |
44/212 |
298/8842 |
3.59E-23 |
8.68E-21 |
7.17E-21 |
CXCL6/CCL4/CCL18/CXCL1/CCL3/CCR5/IL21R/CXCL13/CXCL3/IL10/CXCR4/IL6/IL2RA/IL7R/CCL7/CXCL10/OSM/CCL4L2/CNTFR/IFNG/CCL8/CCR4/CXCL2/IL2RG/CXCR6/CCR2/CXCL11/CXCL9/XCL2/XCL1/FASLG/IL1B/TNFRSF17/GDF10/CCR7/CCL13/IFNE/CD27/CCL19/BMP5/IL1RN/CCL20/LEP/TNFRSF6B |
44 |
| hsa04061 |
Viral protein interaction with cytokine and cytokine receptor |
28/212 |
100/8842 |
7.99E-23 |
9.67E-21 |
7.99E-21 |
CXCL6/CCL4/CCL18/CXCL1/CCL3/CCR5/CXCL13/CXCL3/IL10/CXCR4/IL6/IL2RA/CCL7/CXCL10/CCL4L2/CCL8/CCR4/CXCL2/IL2RG/CCR2/CXCL11/CXCL9/XCL2/XCL1/CCR7/CCL13/CCL19/CCL20 |
28 |
| hsa04062 |
Chemokine signaling pathway |
27/212 |
193/8842 |
7.60E-14 |
6.13E-12 |
5.07E-12 |
CXCL6/CCL4/CCL18/CXCL1/CCL3/CCR5/CXCL13/CXCL3/CXCR4/CCL7/CXCL10/CCL4L2/CCL8/CCR4/CXCL2/CXCR6/CCR2/CXCL11/CXCL9/XCL2/ADCY5/XCL1/ITK/CCR7/CCL13/CCL19/CCL20 |
27 |
| hsa04640 |
Hematopoietic cell lineage |
17/212 |
99/8842 |
1.47E-10 |
8.88E-09 |
7.34E-09 |
FCGR1A/HLA-DQA1/HLA-DRA/IL6/IL2RA/IL7R/ITGA4/CD2/CR1/CD38/CD3D/HLA-DOB/IL1B/CD3G/CR2/MS4A1/CD19 |
17 |
| hsa05323 |
Rheumatoid arthritis |
16/212 |
94/8842 |
5.97E-10 |
2.89E-08 |
2.39E-08 |
MMP1/MMP3/CXCL6/HLA-DQA1/CXCL1/CD80/HLA-DRA/CCL3/CXCL3/IL6/CTLA4/IFNG/CXCL2/HLA-DOB/IL1B/CCL20 |
16 |
| hsa04657 |
IL-17 signaling pathway |
15/212 |
95/8842 |
6.16E-09 |
2.48E-07 |
2.05E-07 |
MMP1/MMP3/CXCL6/CXCL1/MMP13/CXCL3/IL6/CCL7/CXCL10/IFNG/CXCL2/S100A9/IL1B/S100A8/CCL20 |
15 |
| hsa05332 |
Graft-versus-host disease |
10/212 |
44/8842 |
6.18E-08 |
2.14E-06 |
1.77E-06 |
HLA-DQA1/CD80/HLA-DRA/IL6/IFNG/HLA-DOB/GZMB/FASLG/IL1B/KLRC1 |
10 |
| hsa04672 |
Intestinal immune network for IgA production |
10/212 |
49/8842 |
1.84E-07 |
5.58E-06 |
4.61E-06 |
HLA-DQA1/CD80/HLA-DRA/IL10/CXCR4/IL6/ICOS/ITGA4/HLA-DOB/TNFRSF17 |
10 |
| hsa04659 |
Th17 cell differentiation |
14/212 |
108/8842 |
2.59E-07 |
6.95E-06 |
5.75E-06 |
HLA-DQA1/HLA-DRA/IL21R/IL6/IL2RA/IFNG/IL2RG/CD3D/HLA-DOB/IL1B/IRF4/RXRG/CD3G/LCK |
14 |
| hsa03320 |
PPAR signaling pathway |
11/212 |
76/8842 |
1.70E-06 |
4.11E-05 |
3.39E-05 |
MMP1/RXRG/OLR1/ACADL/PLIN4/PLIN1/AQP7/PLIN5/FABP4/ADIPOQ/PCK1 |
11 |
| hsa05330 |
Allograft rejection |
8/212 |
38/8842 |
2.52E-06 |
5.54E-05 |
4.58E-05 |
HLA-DQA1/CD80/HLA-DRA/IL10/IFNG/HLA-DOB/GZMB/FASLG |
8 |
| hsa04514 |
Cell adhesion molecules |
15/212 |
157/8842 |
5.00E-06 |
0.0001008 |
8.33E-05 |
HLA-DQA1/CD80/HLA-DRA/SELE/ICOS/ITGA4/CTLA4/CD2/TIGIT/HLA-DOB/CD274/CNTN2/PDCD1/NRXN1/SDC1 |
15 |
| hsa04940 |
Type I diabetes mellitus |
8/212 |
43/8842 |
6.74E-06 |
0.0001255 |
0.0001037 |
HLA-DQA1/CD80/HLA-DRA/IFNG/HLA-DOB/GZMB/FASLG/IL1B |
8 |
| hsa04064 |
NF-kappa B signaling pathway |
12/212 |
105/8842 |
7.27E-06 |
0.0001256 |
0.0001038 |
CCL4/LBP/CXCL1/BCL2A1/CXCL3/CCL4L2/CXCL2/BIRC3/IL1B/CCL13/LCK/CCL19 |
12 |
| hsa04620 |
Toll-like receptor signaling pathway |
12/212 |
109/8842 |
1.07E-05 |
0.000173 |
0.000143 |
CCL4/LBP/CD80/CCL3/IL6/CXCL10/CCL4L2/TLR8/SPP1/CXCL11/CXCL9/IL1B |
12 |
| hsa05140 |
Leishmaniasis |
10/212 |
77/8842 |
1.37E-05 |
0.0002074 |
0.0001714 |
FCGR1A/HLA-DQA1/HLA-DRA/FCGR3A/IL10/ITGA4/IFNG/CR1/HLA-DOB/IL1B |
10 |
| hsa05144 |
Malaria |
8/212 |
50/8842 |
2.16E-05 |
0.0002934 |
0.0002425 |
IL10/IL6/SELE/IFNG/CR1/KLRB1/IL1B/SDC1 |
8 |
| hsa05321 |
Inflammatory bowel disease |
9/212 |
65/8842 |
2.20E-05 |
0.0002934 |
0.0002425 |
HLA-DQA1/HLA-DRA/IL21R/IL10/IL6/IFNG/IL2RG/HLA-DOB/IL1B |
9 |
| hsa05143 |
African trypanosomiasis |
7/212 |
37/8842 |
2.30E-05 |
0.0002934 |
0.0002425 |
IL10/IL6/SELE/IFNG/IDO1/FASLG/IL1B |
7 |
| hsa05340 |
Primary immunodeficiency |
7/212 |
38/8842 |
2.77E-05 |
0.0003348 |
0.0002767 |
IL7R/ICOS/IL2RG/CD3D/CD79A/LCK/CD19 |
7 |
| hsa05320 |
Autoimmune thyroid disease |
8/212 |
53/8842 |
3.35E-05 |
0.0003864 |
0.0003193 |
HLA-DQA1/CD80/HLA-DRA/IL10/CTLA4/HLA-DOB/GZMB/FASLG |
8 |
| hsa04668 |
TNF signaling pathway |
11/212 |
119/8842 |
0.0001268 |
0.0013949 |
0.0011528 |
MMP3/CXCL6/CXCL1/CXCL3/IL6/SELE/CXCL10/CXCL2/BIRC3/IL1B/CCL20 |
11 |
| hsa04658 |
Th1 and Th2 cell differentiation |
9/212 |
92/8842 |
0.0003426 |
0.0036044 |
0.0029788 |
HLA-DQA1/HLA-DRA/IL2RA/IFNG/IL2RG/CD3D/HLA-DOB/CD3G/LCK |
9 |
| hsa04923 |
Regulation of lipolysis in adipocytes |
7/212 |
59/8842 |
0.0004884 |
0.0049249 |
0.0040701 |
ADCY5/PLIN1/LIPE/AQP7/NPY1R/CIDEC/FABP4 |
7 |
| hsa05150 |
Staphylococcus aureus infection |
9/212 |
100/8842 |
0.000636 |
0.0060513 |
0.005001 |
FCGR1A/HLA-DQA1/HLA-DRA/FCGR3A/IL10/FPR1/HLA-DOB/FCAR/FPR2 |
9 |
| hsa04936 |
Alcoholic liver disease |
11/212 |
144/8842 |
0.0006671 |
0.0060513 |
0.005001 |
LBP/CXCL1/TCF7L1/CXCL3/IL6/CXCL2/FASLG/IL1B/ADH1C/ADH1B/ADIPOQ |
11 |
| hsa04660 |
T cell receptor signaling pathway |
10/212 |
122/8842 |
0.0006751 |
0.0060513 |
0.005001 |
IL10/ICOS/CTLA4/IFNG/CD3D/RASGRP1/ITK/CD3G/LCK/PDCD1 |
10 |
| hsa05152 |
Tuberculosis |
12/212 |
180/8842 |
0.0012813 |
0.0110742 |
0.0091523 |
FCGR1A/LBP/HLA-DQA1/HLA-DRA/FCGR3A/IL10/IL6/IFNG/CR1/HLA-DOB/IL1B/CLEC4E |
12 |
| hsa05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |
8/212 |
90/8842 |
0.0013744 |
0.0114691 |
0.0094786 |
BATF/IFNG/CD3D/CD274/RASGRP1/CD3G/LCK/PDCD1 |
8 |
| hsa05417 |
Lipid and atherosclerosis |
13/212 |
216/8842 |
0.002054 |
0.0165161 |
0.0136497 |
MMP1/MMP3/LBP/CXCL1/CCL3/CXCL3/IL6/SELE/CXCL2/FASLG/IL1B/RXRG/OLR1 |
13 |
| hsa05134 |
Legionellosis |
6/212 |
56/8842 |
0.0021157 |
0.0165161 |
0.0136497 |
CXCL1/CXCL3/IL6/CR1/CXCL2/IL1B |
6 |
| hsa04630 |
JAK-STAT signaling pathway |
11/212 |
168/8842 |
0.002336 |
0.0176657 |
0.0145997 |
IL21R/IL10/IL6/IL2RA/IL7R/OSM/CNTFR/IFNG/IL2RG/IFNE/LEP |
11 |
| hsa00380 |
Tryptophan metabolism |
5/212 |
42/8842 |
0.0031237 |
0.0229072 |
0.0189315 |
KMO/KYNU/IDO1/TDO2/IL4I1 |
5 |
| hsa05142 |
Chagas disease |
8/212 |
103/8842 |
0.0032355 |
0.0230295 |
0.0190326 |
CCL3/IL10/IL6/IFNG/CD3D/FASLG/IL1B/CD3G |
8 |
| hsa04623 |
Cytosolic DNA-sensing pathway |
7/212 |
83/8842 |
0.0036649 |
0.0253402 |
0.0209423 |
CCL4/AIM2/IL6/CXCL10/CCL4L2/IL1B/ZBP1 |
7 |
| hsa04512 |
ECM-receptor interaction |
7/212 |
89/8842 |
0.0053928 |
0.0362515 |
0.0299599 |
TNXB/HMMR/ITGA4/SPP1/COL6A5/ITGA11/SDC1 |
7 |
| hsa05310 |
Asthma |
4/212 |
31/8842 |
0.0060839 |
0.0391752 |
0.0323762 |
HLA-DQA1/HLA-DRA/IL10/HLA-DOB |
4 |
| hsa05322 |
Systemic lupus erythematosus |
9/212 |
139/8842 |
0.0061515 |
0.0391752 |
0.0323762 |
FCGR1A/HLA-DQA1/CD80/HLA-DRA/FCGR3A/IL10/IFNG/HLA-DOB/C6 |
9 |
|